Does Infection With Specific Clostridium difficile Strains or Clades Influence Clinical Outcome?
CLINICAL INFECTIOUS DISEASES (2013)
期刊
CLINICAL INFECTIOUS DISEASES
卷 56, 期 11, 页码 1601-1603出版社
OXFORD UNIV PRESS INC
关键词
作者
我是这篇论文的作者
推荐
A Novel Surgical Treatment of Pediatric Fulminant Clostridium difficile Colitis
Ryan M. Hanson, Amy J. Wagner
PEDIATRICS (2022)
Clostridioides (Clostridium) difficile
Ibrahim A. Al-Zahrani
SAUDI MEDICAL JOURNAL (2023)
Clostridium difficile infection after orthopedic surgery: Incidence, associated factors, and impact on outcome
Dong Youn Kim, Yu-Mi Lee, Ki-Ho Park, Young Jin Kim, Kyung-Chung Kang, Chang Kyun Lee, Mi Suk Lee
AMERICAN JOURNAL OF INFECTION CONTROL (2022)
Gut Microbiota and Clostridium difficile: What We Know and the New Frontiers
Andrea Piccioni, Federico Rosa, Federica Manca, Giulia Pignataro, Christian Zanza, Gabriele Savioli, Marcello Covino, Veronica Ojetti, Antonio Gasbarrini, Francesco Franceschi, Marcello Candelli
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Characterization of the virulence of three novel clade 2 Clostridioides (Clostridium) difficile strains and a two-year screening in animals and humans in Brazil
Amanda Nadia Diniz, Loren Nery Fontoura Moura, Diogo Soares Goncalves Cruz, Carlos Augusto Oliveira Junior, Henrique Cesar Pereira Figueiredo, Joao Luis Reis Cunha, Eduardo Garcia Vilela, Edward J. Kuijper, Mark H. Wilcox, Francisco Carlos Faria Lobato, Rodrigo Otavio Silveira Silva
PLOS ONE (2022)
Design and characterization of a novel lytic protein against Clostridium difficile
Meng Wang, Zifeng Deng, Yanmei Li, Yi Ma, Jufang Wang
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2022)
Inhibition of Clostridium difficile TcdA and TcdB toxins with transition state analogues
Ashleigh S. Paparella, Briana L. Aboulache, Rajesh K. Harijan, Kathryn S. Potts, Peter C. Tyler, Vern L. Schramm
NATURE COMMUNICATIONS (2021)
Clostridium difficile Infection Reservoirs Within an Acute Rehabilitation Environment
Justin Weppner, Joelle Gabet, Mark Linsenmeyer, Mohamed Yassin, Gary Galang
AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION (2021)
Antimicrobial resistance surveillance of Clostridioides difficile in Australia, 2015-18
Papanin Putsathit, Stacey Hong, Narelle George, Christine Hemphill, Peter G. Huntington, Tony M. Korman, Despina Kotsanas, Monica Lahra, Rodney McDougall, Andrew McGlinchey, Casey Moore, Graeme R. Nimmo, Louise Prendergast, Jennifer Robson, Lynette Waring, Michael C. Wehrhahn, Gerhard F. Weldhagen, Richard M. Wilson, Thomas Riley, Daniel R. Knight
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)
TFPI is a colonic crypt receptor for TcdB from hypervirulent clade 2 C. difficile
Jianhua Luo, Qi Yang, Xiaofeng Zhang, Yuanyuan Zhang, Li Wan, Xiechao Zhan, Yao Zhou, Liuqing He, Danyang Li, Dazhi Jin, Ying Zhen, Jing Huang, Yanyan Li, Liang Tao
CELL (2022)
Incidence and predictive biomarkers of Clostridioides difficile infection in hospitalized patients receiving broad-spectrum antibiotics
Cornelis H. van Werkhoven, Annie Ducher, Matilda Berkell, Mohamed Mysara, Christine Lammens, Julian Torre-Cisneros, Jesus Rodriguez-Bano, Delia Herghea, Oliver A. Cornely, Lena M. Biehl, Louis Bernard, M. Angeles Dominguez-Luzon, Sofia Maraki, Olivier Barraud, Maria Nica, Nathalie Jazmati, Frederique Sablier-Gallis, Jean de Gunzburg, France Mentre, Surbhi Malhotra-Kumar, Marc J. M. Bonten, Maria J. G. T. Vehreschild
NATURE COMMUNICATIONS (2021)
Risk factors for clostridium difficile infection in general surgery patients
Alexis Hess, Saskya Byerly, Emily Lenart, Cory Evans, Andrew Kerwin, Dina Filiberto
AMERICAN JOURNAL OF SURGERY (2023)
Clostridium butyricum enhances colonization resistance against Clostridioides difficile by metabolic and immune modulation
Mao Hagihara, Tadashi Ariyoshi, Yasutoshi Kuroki, Shuhei Eguchi, Seiya Higashi, Takeshi Mori, Tsunemasa Nonogaki, Kenta Iwasaki, Makoto Yamashita, Nobuhiro Asai, Yusuke Koizumi, Kentaro Oka, Motomichi Takahashi, Yuka Yamagishi, Hiroshige Mikamo
SCIENTIFIC REPORTS (2021)
Butyrate Protects against Clostridium difficile Infection by Regulating Bile Acid Metabolism
Siqi Wang, Leyang Xiang, Fang li, Wenlin Deng, Pinjing Lv, Ye Chen
MICROBIOLOGY SPECTRUM (2023)
History of Cholecystectomy and Risk of Clostridium Difficile Infection
Anqi Jin, Tony Chien, Qiwen Huang, Pragati Kenkare, Mai Vu, Sandra Wilson, Edward S. Huang
DIGESTIVE DISEASES AND SCIENCES (2021)
Healthcare facility-onset, healthcare facilityassociated Clostridioides difficile infection in Veterans with spinal cord injury and disorder
Charlesnika T. Evans, Margaret Fitzpatrick, Swetha Ramanathan, Stephen M. Kralovic, Stephen P. Burns, Barry Goldstein, Bridget Smith, Dale N. Gerding, Stuart Johnson
JOURNAL OF SPINAL CORD MEDICINE (2020)
Perils and pitfalls of probiotic quasi-experimental studies for primary prevention of Clostridioides difficile infection: A review of the evidence
Lynne McFarland, Stuart B. Johnson, Charlesnika T. Evans
AMERICAN JOURNAL OF INFECTION CONTROL (2021)
Efficacy of Bezlotoxumab in Trial Participants Infected With Clostridioides difficile Strain BI Associated With Poor Outcomes
Stuart Johnson, Diane M. Citron, Dale N. Gerding, Mark H. Wilcox, Ellie J. C. Goldstein, Susan P. Sambol, Emma L. Best, Karen Eves, Erin Jensen, Mary Beth Dorr
CLINICAL INFECTIOUS DISEASES (2021)
The Relative Role of Toxins A and B in the Virulence of Clotridioides difficile
Andrew M. Skinner, S. Tyler Phillips, Michelle M. Merrigan, Kevin J. O'Leary, Susan P. Sambol, Farida Siddiqui, Lance R. Peterson, Dale N. Gerding, Stuart Johnson
JOURNAL OF CLINICAL MEDICINE (2021)
A Tapered-pulsed Fidaxomicin Regimen Following Treatment in Patients With Multiple Clostridioides difficile Infection Recurrences
Andrew M. Skinner, Xing Tan, Benjamin D. Sirbu, Larry H. Danziger, Dale N. Gerding, Stuart Johnson
CLINICAL INFECTIOUS DISEASES (2021)
Potential Roles for Probiotics in the Treatment of COVID-19 Patients and Prevention of Complications Associated with Increased Antibiotic Use
Ravina Kullar, Stuart Johnson, Lynne V. McFarland, Ellie J. C. Goldstein
ANTIBIOTICS-BASEL (2021)
Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults
Stuart Johnson, Valery Lavergne, Andrew M. Skinner, Anne J. Gonzales-Luna, Kevin W. Garey, Ciaran P. Kelly, Mark H. Wilcox
CLINICAL INFECTIOUS DISEASES (2021)
Why Do ACG and AGA Guidelines Differ for the Use of Probiotics and the Prevention of CDI?
Lynne V. McFarland, Ravina Kullar, Stuart Johnson, Jason C. Sniffen, Kristin Woolard, Ellie J. C. Goldstein
AMERICAN JOURNAL OF GASTROENTEROLOGY (2022)
Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trial
Robert Orenstein, Erik R. Dubberke, Sahil Khanna, Christine H. Lee, David Yoho, Stuart Johnson, Gail Hecht, Herbert L. DuPont, Dale N. Gerding, Ken F. Blount, Sarah Mische, Adam Harvey
BMC INFECTIOUS DISEASES (2022)
Can Clostridium innocuum Masquerade as Clostridioides difficile?
Andrew M. Skinner, Laurica Petrella, Stacey Spandoni, Fidel Serna-Perez, Stuart Johnson
CLINICAL INFECTIOUS DISEASES (2022)
Defining optimal treatment for recurrent Clostridioides difficile infection (OpTION study): A randomized, double-blind comparison of three antibiotic regimens for patients with a first or second recurrence
Stuart Johnson, Dale N. Gerding, Xue Li, Domenic J. Reda, Curtis J. Donskey, Kalpana Gupta, Matthew Bidwell Goetz, Michael W. Climo, Fred M. Gordin, Robert Ringer, Neil Johnson, Michelle Johnson, Lawrence A. Calais, Alexa M. Goldberg, Ling Ge, Tamara Haegerich
CONTEMPORARY CLINICAL TRIALS (2022)
Absence of toxin gene transfer from Clostridioides difficile strain 630Δerm to nontoxigenic C. difficile strain NTCD-M3r in filter mating experiments
Susan P. Sambol, Stuart Johnson, Adam Cheknis, Dale N. Gerding
PLOS ONE (2022)
Antimicrobial susceptibility of Clostridioides difficile to omadacycline and comparator antimicrobials
Andrew M. Skinner, Laurica A. Petrella, Adam Cheknis, Stuart Johnson
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)
Effective Colonization by Nontoxigenic Clostridioides difficile REA Strain M3 (NTCD-M3) Spores following Treatment with Either Fidaxomicin or Vancomycin
Susan P. Sambol, Andrew M. Skinner, Fidel Serna-Perez, Benjamin Owen, Dale N. Gerding, Stuart Johnson
MICROBIOLOGY SPECTRUM (2023)
Unique Clindamycin-Resistant Clostridioides difficile Strain Related to Fluoroquinolone-Resistant Epidemic BI/RT027 Strain
Andrew M. Skinner, Laurica Petrella, Farida Siddiqui, Susan P. Sambol, Christopher A. Gulvik, Dale N. Gerding, Curtis J. Donskey, Stuart Johnson
EMERGING INFECTIOUS DISEASES (2020)